Abstract:Primary graft dysfunction (PGD) and chronic lung allograft dysfunction (CLAD) are critical challenges in lung transplantation. Dysregulated gene expression and epigenomic states in lung mesenchymal cells (MCs) play a key role in these conditions, but further work is needed to elucidate the biomarkers and molecular drivers. Single-cell multi-omic technologies offer an unprecedented opportunity to address this gap by jointly measuring gene expression and chromatin accessibility in diseased and healthy cells. We performed single-cell multi-omic profiling and genetic demultiplexing on MCs isolated from human bronchoalveolar lavage samples of lung transplant recipients with CLAD and PGD, compared with time-matched controls. A classification model trained on these profiles classified the disease status of individual cells with > 98% accuracy using a small set of signature genes. We further identified 8 subtypes of MCs each characterized by distinct transcriptomic and epigenomic signatures, including a CLAD-enriched subtype and a PGD-enriched subtype. The CLAD-enriched subtype expresses markers of fibrosis, while the PGD-enriched subtype expresses pro-inflammatory genes. Finally, we used co-accessibility and co-expression to identify C/EBPD, SOX4, and FOXP2 as key regulators of the genes and chromatin accessibility peaks that are dysregulated in the CLAD-enriched cell population. Knocking down C/EBPD with siRNA partially reverted the CLAD gene expression signature, confirming the importance of this factor in the dysregulated molecular state of CLAD-associated MCs. Additional scRNA-seq analysis of MCs from human lung autopsy samples showed that cultured MCs retained key transcriptomic signatures from their in vivo counterparts. Sub-clustering analysis identified a CLAD-enriched MC sub-cluster with high C/EBPD expression, further linking these cells to the fibrotic state seen in vitro. Our results provide deeper insights into the transcriptomic and epigenomic changes in post-transplant MCs, nominating biomarkers and disease-associated factors with implications for future therapeutic efforts.

MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant ischemia-reperfusion injury

MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injury

Monocytic myeloid-derived suppressor cells mediate the resolution of lung ischemia-reperfusion injury via MerTK-dependent efferocytosis

Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

CX3CR1 deficiency promotes resolution of hepatic ischemia-reperfusion injury by regulating homeostatic function of liver infiltrating macrophages

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

CD94+ natural killer cells potentiate pulmonary ischaemia-reperfusion injury

B cells mediate lung ischemia/reperfusion injury by recruiting classical monocytes via synergistic B cell receptor/TLR4 signaling

Single-cell multi-omic analysis of post-transplant mesenchymal cells reveals molecular signatures and putative regulators of lung fibrosis

Downregulation of Tumor Suppressor Gene LKB1 During Severe Primary Graft Dysfunction After Human Lung Transplantation: Implication for the Development of Chronic Lung Allograft Dysfunction

Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation

Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury

The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study

Lipoxin A4 mitigates ferroptosis via FPR2 signaling during lung ischemia-reperfusion injury

Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment

Inhibition of ALOX12-12-HETE Alleviates Lung Ischemia-Reperfusion Injury by Reducing Endothelial Ferroptosis-Mediated Neutrophil Extracellular Trap Formation